Royal Bank of Canada’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $109K | Buy |
+40,193
| New | +$109K | ﹤0.01% | 5225 |
|
2024
Q3 | – | Sell |
-40
| Closed | – | – | 6507 |
|
2024
Q2 | $0 | Hold |
40
| – | – | ﹤0.01% | 6733 |
|
2024
Q1 | $0 | Sell |
40
-68
| -63% | – | ﹤0.01% | 6634 |
|
2023
Q4 | $0 | Sell |
108
-158,099
| -100% | – | ﹤0.01% | 6660 |
|
2023
Q3 | $217K | Sell |
158,207
-115,138
| -42% | -$158K | ﹤0.01% | 4251 |
|
2023
Q2 | $374K | Buy |
+273,345
| New | +$374K | ﹤0.01% | 3774 |
|
2022
Q4 | – | Sell |
-38
| Closed | – | – | 6832 |
|
2022
Q3 | $0 | Buy |
+38
| New | – | ﹤0.01% | 7018 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 6537 |
|
2020
Q3 | – | Sell |
-25
| Closed | – | – | 6166 |
|
2020
Q2 | $0 | Buy |
25
+11
| +79% | – | ﹤0.01% | 6169 |
|
2020
Q1 | $0 | Buy |
+14
| New | – | ﹤0.01% | 6174 |
|
2019
Q4 | – | Sell |
-14
| Closed | – | – | 6230 |
|
2019
Q3 | $0 | Buy |
+14
| New | – | ﹤0.01% | 6029 |
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 5782 |
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 5881 |
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6138 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 5765 |
|
2017
Q4 | – | Sell |
-22
| Closed | -$2K | – | 5828 |
|
2017
Q3 | $2K | Hold |
22
| – | – | ﹤0.01% | 5789 |
|
2017
Q2 | $2K | Buy |
22
+20
| +1,000% | +$1.82K | ﹤0.01% | 5505 |
|
2017
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 5907 |
|
2016
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 5863 |
|
2016
Q1 | – | Hold |
0
| – | – | – | 5650 |
|
2015
Q4 | – | Sell |
-2
| Closed | -$4K | – | 5887 |
|
2015
Q3 | $4K | Sell |
2
-3
| -60% | -$6K | ﹤0.01% | 5619 |
|
2015
Q2 | $10K | Buy |
+5
| New | +$10K | ﹤0.01% | 5541 |
|